Cadre Holdings, Inc.

CDRE ·Healthcare, Medical Devices, United States
Financial Statements › Income Statement
Annual Quarterly

Income Statement

Line Item Jun 2026 Mar 2026 Dec 2025 Sep 2025 Jun 2025 Mar 2025 Dec 2024 Sep 2024
Revenue $207.1M $155.4M $167.2M $155.9M $157.1M $130.1M $176.0M $109.4M
Cost of Revenue $120.0M $95.3M $94.6M $89.2M $92.9M $74.0M $98.8M $69.4M
Gross Profit $87.1M $60.2M $72.6M $66.6M $64.2M $56.1M $77.2M $40.0M
Gross Margin 42.1% 38.7% 43.4% 42.7% 40.9% 43.1% 43.9% 36.6%
Operating Expenses
Research & Development — — — — — — — —
SG&A Expense $63.2M $48.8M $50.6M $45.6M $45.1M $41.8M $45.0M $34.0M
Operating Income $22.5M $7.5M $20.4M $18.7M $14.7M $13.6M $29.4M $5.4M
Operating Margin 10.8% 4.8% 12.2% 12.0% 9.3% 10.4% 16.7% 5.0%
Interest Expense — — — — — — — —
Pretax Income $16.9M $2.8M $17.7M $14.8M $17.2M $12.6M $22.7M $5.0M
Income Tax Expense $5.5M $856.0K $5.9M $3.9M $5.0M $3.4M $9.7M $1.3M
Net Income $11.4M $2.0M $11.7M $10.9M $12.2M $9.2M $13.0M $3.7M
Net Margin 5.5% 1.3% 7.0% 7.0% 7.8% 7.1% 7.4% 3.3%
EPS (Basic) $0.27 $0.05 $0.28 $0.27 $0.30 $0.23 $0.32 $0.09
EPS (Diluted) $0.26 $0.05 $0.22 $0.27 $0.30 $0.23 $0.32 $0.09
Shares Outstanding (Basic) 42.8M 42.6M 40.9M 40.7M 40.7M 40.6M 39.9M 40.6M
Shares Outstanding (Diluted) 43.4M 43.4M 43.4M 41.0M 40.9M 41.0M 40.3M 40.9M
Dividends Per Share $0.10 $0.10 $0.10 $0.10 $0.10 $0.10 $-0.18 $0.09
← Newer Page 1 of 3 Older →